The objective of this Clinical Nutrition Research Unit (CNRU) is to develop a unified and coherent program in nutrition in relation to cancer prevention and control, by advancing multidisciplinary basic and clinical research, upgrading the training in nutrition and cancer prevention for medical students, physicians and other health professionals, improving the clinical care of cancer patients, particularly preventive aspects, at our medical centers and in the population in general, and providing accurate information on this subject to health professional and the general public. The central focus of our collaborative, inter-institutional program remains nutrition and cancer prevention and control. The Clinical Nutrition Research Unit represents the central mechanism for coordinating the major efforts on this focus of the six participating institutions: 1) The American Health Foundation; 2) Memorial Sloan-Kettering Cancer Center; 3) Weill Medical College of Cornell University- New York Presbyterian Hospital; 4) The Rockefeller University; 5) The Strang Cancer Prevention Center; and 6) The Westchester Medical Center-New York Medical College. Our program comprises the four required components of a CNRU: (1) Research with human subjects and populations; (2) Basic laboratory Investigations; (3) Research training (funds derived from other sources); (4) Shared facilities and research services, as well as the three encouraged components; (5) Education programs for medical students, house staff, practicing physicians and allied health personnel (funds derived from other sources); (6) Research components of nutritional support services; and (7) Public information activities (funds derived from other sources). The methods for achieving these goals include providing continuing support for the Administrative Core and three CNRU Core Laboratories: (a) Biostatistics, (b) Immunology, and Carcinogenesis and Nutrition and establishing two proposed new Core Labs (e) Retinoids Analysis and (f) Biomarkers for Cancer Susceptibility. Funds for four pilot studies per year enable novel ideas in nutrition and cancer prevention and control to be tested by both new and established investigators; funds for a New Investigator provide support for a promising junior scientist. Our enrichment program provides a wide range of lectures, conferences and meetings to stimulate interactions among scientists and to keep them current on advancements in the field of cancer prevention and control. The overall scientific and administrative progress of the CNRU is evaluated by External and Internal Advisory Committees, who consult with the program director and the Administrative Core. Highlights of accomplishments made possible by the CNRU to date consist of significant methodological and conceptual advances in both basic and clinical research in nutrition in relation to cancer prevention and control, increasing awareness of the importance of nutrition among health professionals and developing the first required teaching of nutrition for medical students at Weill Medical College of Cornell University.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA029502-21
Application #
6718221
Study Section
Special Emphasis Panel (ZCA1-GRB-F (J1))
Program Officer
Milner, John A
Project Start
1985-07-01
Project End
2007-03-31
Budget Start
2003-05-19
Budget End
2004-03-31
Support Year
21
Fiscal Year
2003
Total Cost
$666,398
Indirect Cost
Name
Institute for Cancer Prevention
Department
Type
DUNS #
City
Valhalla
State
NY
Country
United States
Zip Code
10595
Telang, Nitin (2018) Anti-inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer. Oncol Lett 15:642-648
Telang, Nitin (2015) Putative cancer-initiating stem cells in cell culture models for molecular subtypes of clinical breast cancer. Oncol Lett 10:3840-3846
Telang, Nitin; Katdare, Meena (2011) Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review). Oncol Rep 25:1195-201
Protiva, Petr; Mason, Joel B; Liu, Zhenhua et al. (2011) Altered folate availability modifies the molecular environment of the human colorectum: implications for colorectal carcinogenesis. Cancer Prev Res (Phila) 4:530-43
Cunningham-Rundles, Susanna; Ahrné, Siv; Johann-Liang, Rosemary et al. (2011) Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Nutrients 3:1042-70
Hsieh, Tze-chen; Wu, Joseph M (2010) Resveratrol: Biological and pharmaceutical properties as anticancer molecule. Biofactors 36:360-9
Cheng, Yu-Wei; Idrees, Kamran; Shattock, Richard et al. (2010) Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer. Int J Cancer 127:568-77
Moon, Aeri; Solomon, Aliza; Beneck, Debra et al. (2009) Positive association between Helicobacter pylori and gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr 49:283-8
Cunningham-Rundles, Susanna; Lin, Hong; Ho-Lin, Deborah et al. (2009) Role of nutrients in the development of neonatal immune response. Nutr Rev 67 Suppl 2:S152-63
Spangler, Rudolph; Goddard, Noel L; Spangler, Douglas N et al. (2009) Tests of the single-hit DNA damage model. J Mol Biol 392:283-300

Showing the most recent 10 out of 28 publications